Coviu to integrate ResApp diagnostic app into telehealth platform

ASX-listed digital health company ResApp is working with telehealth software developer Coviu to integrate ResApp’s acute respiratory diagnostic app into Coviu’s platform to help clinicians diagnose respiratory disease in a telehealth setting.

ResAppDx-EU is a TGA-approved smartphone app that uses machine learning algorithms that analyse a patient’s cough sounds to diagnose disease.

Posted in Australian eHealth

Tags: Coviu, ResApp Health

Add comment

Please note comments of a self-promotional nature are likely to be deleted.

Security code

Sign up for Pulse+IT eNewsletters

Sign up for Pulse+IT website access

For more information, click here.

Copyright © 2020 Pulse+IT Magazine
No content published on this website can be reproduced by any person for any reason without the prior written permission of the publisher.